Status:
COMPLETED
MCG Discovery Study in Emergency Departments
Lead Sponsor:
SB Technology, Inc.
Conditions:
ACS - Acute Coronary Syndrome
NSTEMI - Non-ST Segment Elevation MI
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This prospective discovery study is designed to demonstrate the feasibility of using an unshielded, mobile MCG device in an Emergency Department (ED) setting. The main question it aims to answer is wh...
Eligibility Criteria
Inclusion
- Presents to ED with symptoms of Acute Coronary Syndrome (ACS)
- Can provide written consent
Exclusion
- Presents to ED with ST-Elevation Myocardial Infarction (STEMI)
- Presents to ED with Atrial Fibrillation
- Clear non-ischemic cause for symptoms (i.e. trauma)
- Active thoracic metal implants
Key Trial Info
Start Date :
October 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 8 2025
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT06095557
Start Date
October 30 2023
End Date
July 8 2025
Last Update
October 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029